{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:18:10Z","timestamp":1715998690780},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.01.011","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T14:52:38Z","timestamp":1235487158000},"page":"130-140","source":"Crossref","is-referenced-by-count":18,"title":["Patients\u2019 experiences of niacin-induced flushing in clinical practice: A structured telephone interview"],"prefix":"10.1016","volume":"31","author":[{"given":"Sachin","family":"Kamal-Bahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishali M.","family":"Ambegaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.01.011_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: A meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.164.7.697","article-title":"New perspectives on the use of niacin in the treatment of lipid disorders","volume":"164","author":"McKenney","year":"2004","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.clinthera.2009.01.011_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2004.03.042","article-title":"A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women","volume":"94","author":"Goldberg","year":"2004","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib4","first-page":"229","article-title":"Increasing HDL cholesterol with extended-release nicotinic acid: From promise to practice","volume":"62","author":"Birjmohun","year":"2004","journal-title":"Neth J Med."},{"key":"10.1016\/j.clinthera.2009.01.011_bib5","first-page":"165","article-title":"The effect of aspirin on niacin-induced cutaneous reactions","volume":"34","author":"Whelan","year":"1992","journal-title":"J Fam Pract."},{"key":"10.1016\/j.clinthera.2009.01.011_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1525-1497.1997.07118.x","article-title":"Effect of two aspirin pretreatment regimens on niacin-induced cutaneous reactions","volume":"12","author":"Jungnickel","year":"1997","journal-title":"J Cen Intern Med."},{"key":"10.1016\/j.clinthera.2009.01.011_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00045391-199506000-00006","article-title":"Low-dose aspirin and Ibuprofen reduce the cutaneous reactions following niacin administration","volume":"2","author":"Dunn","year":"1995","journal-title":"Am J Ther."},{"key":"10.1016\/j.clinthera.2009.01.011_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5414\/CPP45078","article-title":"Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation","volume":"45","author":"Cefah","year":"2007","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2009.01.011_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.18553\/jmcp.2007.13.8.652","article-title":"LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO","volume":"13","author":"Nag","year":"2007","journal-title":"J Manag Care Pharm."},{"key":"10.1016\/j.clinthera.2009.01.011_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2796.1997.112133000.x","article-title":"The problem of compliance to cholesterol altering therapy","volume":"241","author":"Insull","year":"1997","journal-title":"J Intern Med."},{"key":"10.1016\/j.clinthera.2009.01.011_bib11_1","doi-asserted-by":"crossref","first-page":"74U","DOI":"10.1016\/S0002-9149(98)00731-0","article-title":"Efficacy and safety of an extended-release niacin (Niaspan): A long-term study","volume":"82","author":"Capuzzi","year":"1998","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib11_2","doi-asserted-by":"crossref","first-page":"85U","DOI":"10.1016\/S0002-9149(98)00731-0","article-title":"Efficacy and safety of an extended-release niacin (Niaspan): A long-term study","volume":"82","author":"Capuzzi","year":"1998","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib12","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1185\/030079907X199637","article-title":"Validation of a questionnaire to assess niacin-induced cutaneous flushing","volume":"23","author":"Norquist","year":"2007","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2009.01.011_bib13","series-title":"Design and Analysis of Experiments","year":"2001"},{"key":"10.1016\/j.clinthera.2009.01.011_bib14","series-title":"Applied Logistic Regression","year":"2000"},{"key":"10.1016\/j.clinthera.2009.01.011_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib16_1","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2009.01.011_bib16_2","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2009.01.011_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9149(98)00448-2","article-title":"Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia","volume":"82","author":"Guyton","year":"1998","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib18_1","doi-asserted-by":"crossref","first-page":"29U","DOI":"10.1016\/S0002-9149(98)00732-2","article-title":"A new extended-release niacin (Niaspan): Efficacy, tolerabihty, and safety in hypercholesterolemic patients","volume":"82","author":"Morgan","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2009.01.011_bib18_2","doi-asserted-by":"crossref","first-page":"39U","DOI":"10.1016\/S0002-9149(98)00732-2","article-title":"A new extended-release niacin (Niaspan): Efficacy, tolerabihty, and safety in hypercholesterolemic patients","volume":"82","author":"Morgan","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2009.01.011_bib19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1592\/phco.21.20.1473.34481","article-title":"Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes","volume":"21","author":"Kane","year":"2001","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.clinthera.2009.01.011_bib20","first-page":"437","article-title":"Discontinuation rates of cholesterol-lowering medications: Implications for primary care","volume":"5","author":"Hiatt","year":"1999","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.clinthera.2009.01.011_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2006.08.063","article-title":"Discontinuation of lipid modifying drugs among commercially insured US patients in recent clinical practice","volume":"99","author":"Kamal-Bahl","year":"2007","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.clinthera.2009.01.011_bib22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1185\/030079907X199682","article-title":"Safety and tolerabihty of prolonged-release nicotinic acid in statin-treated patients","volume":"23","author":"Birjmohun","year":"2007","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2009.01.011_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.amjcard.2004.04.024","article-title":"Safety and compliance with once-daily niacin extended-release\/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study","volume":"94","author":"Rubenfire","year":"2004","journal-title":"Am J Cardiol."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T07:36:02Z","timestamp":1633160162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0149291809000253"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.01.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}